NEXT
Sign in to follow

New Jersey Law Journal

New Jersey Pursues Wyeth, a Pfizer Subsidiary, Over Chemical Disposal

The property was used for manufacturing of drugs and chemicals from 1915 to 1999, the suit states. During that period, waste was placed in at least 27 large, pondlike storage and disposal areas that were referred to as impoundments, the suit claims.
4 minute read

New Jersey Law Journal

Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis

"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.
7 minute read

New Jersey Law Journal

Class Action Claims Johnson & Johnson Prescription Plan Overcharges Participants

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.
4 minute read

New York Law Journal

US Judge Ends Antitrust Claim Alleging Conspiracy to Manipulate Prices of Insulin Products

Chief Judge Elizabeth Wolford of U.S. District Court, Western District in Rochester wrote that the plaintiffs failed to present a viable claim under the Sherman Act.
4 minute read

Texas Lawyer

Texas to Receive $21.6M From Publicis Health National $350M Settlement

In the agreed judgement, Publicis Health does not admit any wrongdoing that was alleged by the attorney general.
3 minute read

The Legal Intelligencer

A Pennsylvania Judge Will Oversee Lawsuits Targeting Weight Loss Drug Ozempic

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered 55 cases filed against Eli Lilly and Novo Nordisk over Ozempic, Mounjaro and other medications be coordinated into multidistrict litigation.
3 minute read

New Jersey Law Journal

Clogged Up: Lawsuits Are Flying Against Johnson & Johnson Over Decongestant

On Sept. 12, 2023, the FDA issued a report on phenylephrine, saying that there were no safety issues found with its use as a decongestant but there were also no benefits, the suit said.
3 minute read

Law.com

Did Weight-Loss Wonder Drugs Fail to Warn? 'This Case Is Very Strong Right Now'

About 50 lawsuits so far target Novo Nordisk and Eli Lilly over Type 2 diabetes medications Ozempic, Mounjaro and other medications. Lawyers anticipate 10,000 to 20,000 cases.
7 minute read

Corporate Counsel

Pair of Biopharma Companies Tap Compliance Veterans to Lead Legal

Tris Pharma targets ADHD and addiction, while BPGbio uses an AI platform to discover drug candidates.
5 minute read

New Jersey Law Journal

Big Law Squares Off in Battle Over Prescription Drug Prices

Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.
5 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now